| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89744-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89234-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89235-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-97038-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99174-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90625-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89839-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89841-50ul | |||
![Flow Cytometry: TfR (Transferrin R) Antibody (040) [NBP2-89744] - Analysis of Human TFRC(CD71) expression on U937 cells. Cells were stained with purified anti-Human TFRC(CD71), then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/TfR-Transferrin-R-Antibody-040-Flow-Cytometry-NBP2-89744-img0002.jpg "Flow Cytometry: TfR (Transferrin R) Antibody (040) [NBP2-89744] - Analysis of Human TFRC(CD71) expression on U937 cells. Cells were stained with purified anti-Human TFRC(CD71), then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![Immunocytochemistry/Immunofluorescence: TfR (Transferrin R) Antibody (040) [NBP2-89744] - Staining of Human TFRC in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-89744 antibody (1:60) at 37c 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated goat Anti-rabbit IgG secondary antibody (green). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp2-89744_rabbit-monoclonal-tfr-transferrin-r-antibody-040-235202514492378.png)
![Western Blot: CCR1 Antibody (002) [NBP2-89234] - Lane A: HEK293 Whole Cell Lysate Lane B: 293T Whole Cell LysateLysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:43 kDa Observed band size:49 kDa](http://images.novusbio.com/fullsize/CCR1-Antibody-002-Western-Blot-NBP2-89234-img0001.jpg "Western Blot: CCR1 Antibody (002) [NBP2-89234] - Lane A: HEK293 Whole Cell Lysate Lane B: 293T Whole Cell LysateLysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:43 kDa Observed band size:49 kDa")
![Immunoprecipitation: CCR1 Antibody (002) [NBP2-89234] - Lane A:0.5 mg Hela Whole Cell Lysate Lane B:0.5 mg 293T Whole Cell Lysate2 uL anti-CCR1/CD191 rabbit monoclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-CCR1/CD191 rabbit monoclonal antibody,at 1:100 dilution Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution Developed using the odssey technique. Performed under reducing conditions. Predicted band size: 43 kDa Observed band size: 43 kDa](http://images.novusbio.com/fullsize/CCR1-Antibody-002-Immunoprecipitation-NBP2-89234-img0002.jpg)
![Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human tonsil with rabbit monoclonal antibody (1:500).](http://images.novusbio.com/fullsize/CCR1-Antibody-003-Immunohistochemistry-Paraffin-NBP2-89235-img0002.jpg "Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human tonsil with rabbit monoclonal antibody (1:500).")
![Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human spleen with rabbit monoclonal antibody (1:500).](http://images.novusbio.com/fullsize/CCR1-Antibody-003-Immunohistochemistry-Paraffin-NBP2-89235-img0001.jpg)
![Immunohistochemistry-Paraffin: PSG1 Antibody [NBP2-97038] - Immunochemical staining of human PSG1 in human placenta with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/PSG1-Antibody-Immunohistochemistry-Paraffin-NBP2-97038-img0002.jpg "Immunohistochemistry-Paraffin: PSG1 Antibody [NBP2-97038] - Immunochemical staining of human PSG1 in human placenta with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.")
![Immunohistochemistry-Paraffin: PSG1 Antibody [NBP2-97038] - Immunochemical staining of human PSG1 in human kidney with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/PSG1-Antibody-Immunohistochemistry-Paraffin-NBP2-97038-img0001.jpg)
![Western Blot: IgJ Antibody [NBP2-87622] - WB Suggested Anti-IGJ Antibody. Titration: 1.0 ug/ml. Positive Control: Jurkat Whole Cell](http://images.novusbio.com/fullsize/IgJ-Antibody-Western-Blot-NBP2-87622-img0001.jpg "Western Blot: IgJ Antibody [NBP2-87622] - WB Suggested Anti-IGJ Antibody. Titration: 1.0 ug/ml. Positive Control: Jurkat Whole Cell")
![Western Blot: IgJ Antibody [NBP2-87622] - Host: Rabbit. Target Name: IGJ. Sample Tissue: Human RPMI 8226 Whole Cell. Antibody Dilution: 1ug/ml](http://images.novusbio.com/fullsize/IgJ-Antibody-Western-Blot-NBP2-87622-img0002.jpg)
![Western Blot: APOBEC3B Antibody [NBP2-99174] - Anti-APOBEC3B rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti- Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 46 kDa. Observed band size: 50 kDa (We are unsure as to the identity of these extra bands).](http://images.novusbio.com/fullsize/APOBEC3B-Antibody-Western-Blot-NBP2-99174-img0002.jpg "Western Blot: APOBEC3B Antibody [NBP2-99174] - Anti-APOBEC3B rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti- Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 46 kDa. Observed band size: 50 kDa (We are unsure as to the identity of these extra bands).")
![Immunoprecipitation: APOBEC3B Antibody [NBP2-99174] - APOBEC3B was immunoprecipitated using: Lane A: 0.5 mg 293T Whole Cell Lysate. Lane B: 0.5 mg HepG2 Whole Cell Lysate4 ul anti-APOBEC3B rabbit polyclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-APOBEC3B rabbit polyclonal antibody, at 1:100 dilution. Secondary antibody: Clean-Bloto IP Detection Reagent (HRP) at 1:500 dilution. Developed using the DAB staining technique. Performed under reducing conditions. Predicted band size: 46 kDa. Observed band size: 46 kDa](http://images.novusbio.com/fullsize/APOBEC3B-Antibody-Immunoprecipitation-NBP2-99174-img0001.jpg)
![Western Blot: 15-PGDH/HPGD Antibody (101) [NBP2-90625] - Anti-15-PGDH/HPGD rabbit monoclonal antibody at 1:500 dilution. Lane A: LOVO Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 29 kDa. Observed band size: 27 kDa](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-101-Western-Blot-NBP2-90625-img0003.jpg "Western Blot: 15-PGDH/HPGD Antibody (101) [NBP2-90625] - Anti-15-PGDH/HPGD rabbit monoclonal antibody at 1:500 dilution. Lane A: LOVO Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 29 kDa. Observed band size: 27 kDa")
![Immunoprecipitation: 15-PGDH/HPGD Antibody (101) [NBP2-90625] - Mouse 15-PGDH/HPGD was immunoprecipitated using: Lane A: 0.5 mg Caco-2 Whole Cell Lysate. 2 ul anti-Mouse 15-PGDH/HPGD rabbit monoclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-Mouse 15-PGDH/HPGD rabbit monoclonal antibody, at 1:200 dilution. Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 29 kDa. Observed band size: 29 kDa](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-101-Immunoprecipitation-NBP2-90625-img0004.jpg)
![Flow Cytometry: 15-PGDH/HPGD Antibody (016) [NBP2-89839] - Analysis of Human HPGD expression on Jurkat cells. The cells were treated , stained with purified anti-Human HPGD, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-016-Flow-Cytometry-NBP2-89839-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: 15-PGDH/HPGD Antibody (016) [NBP2-89839] - Analysis of Human HPGD expression on Jurkat cells. The cells were treated , stained with purified anti-Human HPGD, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: 15-PGDH/HPGD Antibody (016) [NBP2-89839] - Staining of Human HPGD in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-89839 antibody (1:60) at 37c 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp2-89839_rabbit-monoclonal-15-pgdh-hpgd-antibody-016-23520251628128.png)
![Flow Cytometry: 15-PGDH/HPGD Antibody (027) [NBP2-89841] - Analysis of Human HPGD expression on Jurkat cells. The cells were treated, stained with purified anti-Human HPGD, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/15-PGDH-HPGD-Antibody-027-Flow-Cytometry-NBP2-89841-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: 15-PGDH/HPGD Antibody (027) [NBP2-89841] - Analysis of Human HPGD expression on Jurkat cells. The cells were treated, stained with purified anti-Human HPGD, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: 15-PGDH/HPGD Antibody (027) [NBP2-89841] - Staining of Human HPGD in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-89841 antibody (1:60) at 37c 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp2-89841_rabbit-monoclonal-15-pgdh-hpgd-antibody-027-23520252135140.png)
![Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Separation of human monocytes (red-filled) from CD109 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD109-Antibody-W7C5-Flow-Cell-Surface-NBP2-75969-img0004.jpg "Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Separation of human monocytes (red-filled) from CD109 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.")
![Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Staining pattern of human peripheral blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD109-Antibody-W7C5-Flow-Cell-Surface-NBP2-75969-img0003.jpg)